Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Bloom Energy CLO Sells 2,870 Shares in Tax-Related Transaction

Shawn Marie Soderberg, Chief Legal Officer and Corporate Secretary of Bloom Energy Corp (NYSE:BE), filed a Form 4 on September 18, 2026, disclosing the sale of 2,870 shares of common stock on September 16, 2026, to cover tax withholding obligations arising from the settlement …

Aditi Sarkar | 18 September 2026

Bloom Energy Chief Accounting Officer Sells 2,295 Shares

Maciej Kurzymski, Chief Accounting Officer of Bloom Energy Corp (NYSE:BE), filed a Form 4 on September 18, 2026, disclosing the sale of 2,295 shares of common stock on September 16, 2026, to cover tax withholding obligations upon the settlement of restricted stock units.

Aakashdeep | 18 September 2026

Bloom Energy CCO Sells 3,601 Shares Under 10b5-1 Plan

Aman Joshi, Chief Commercial Officer of Bloom Energy Corp (NYSE:BE), filed a Form 4 on September 18, 2026, disclosing the sale of 3,601 shares of common stock on September 16, 2026, to cover tax withholding obligations upon the settlement of restricted stock units.

Anjali Anand | 18 September 2026

Nippon Life Buys 320,785 Corebridge Shares in Open Market

Nippon Life Insurance Co filed a Form 4 with the SEC on September 18, 2026, disclosing the purchase of 320,785 shares of Corebridge Financial, Inc. common stock on September 16, 2026, under a Rule 10b5-1 plan.

Aakashdeep | 18 September 2026

IDEX Corp Officer Disposes 290 Shares in Tax Withholding Event

Tara M. Tereso, Group Executive of IDEX Corporation's Health and Science Technologies segment, filed a statement of changes in beneficial ownership on September 18, 2026, reporting a disposition of common stock on September 16, 2026.

Aakashdeep | 18 September 2026

Revolution Medicines Officer Sells Shares Under 10b5-1 Plan

Stephen Michael Kelsey, Senior Advisor to the Chief Executive Officer at Revolution Medicines, Inc. (NASDAQ:RVMD), filed a Form 4 on September 18, 2026, disclosing the sale of common stock on September 16, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

Anjali Anand | 18 September 2026

Revolution Medicines Officer Sells Shares Under 10b5-1 Plan

Anthony Mancini, Chief Global Commercialization Officer of Revolution Medicines, Inc. (NASDAQ:RVMD), filed a Form 4 on September 18, 2026, disclosing the sale of common stock on September 16, 2026 pursuant to a pre-established Rule 10b5-1 trading plan.

Shwetambri Chauhan | 18 September 2026

Revolution Medicines CDO Sells Shares Under 10b5-1 Plan

Alan B. Sandler, Chief Development Officer of Revolution Medicines, Inc. (NASDAQ:RVMD), filed a Form 4 on September 18, 2026, reporting two sales of common stock on September 16, 2026, executed under a pre-established Rule 10b5-1 trading plan.

Aakashdeep | 18 September 2026

Affirm Holdings President Receives 67,006 RSU Grant

Michael Linford, President of Affirm Holdings, Inc., filed a Form 4 on September 18, 2026, disclosing the acquisition of 67,006 restricted stock units in the company's Class A Common Stock on September 16, 2026.

Aakashdeep | 18 September 2026

Affirm Holdings President Receives 67,006 RSU Grant

Libor Michalek, President and Director of Affirm Holdings, Inc. (NASDAQ:AFRM), filed a Form 4 on September 18, 2026, disclosing the acquisition of 67,006 Restricted Stock Units on September 16, 2026.

Anjali Anand | 18 September 2026
Support

Hi! How can we help you today?

Loading…